Susquehanna International Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-363,758
| Closed | -$8.77M | – | 6866 |
|
|
2023
Q1 | $8.77M | Buy |
363,758
+248,847
| +217% | +$6M | ﹤0.01% | 802 |
|
|
2022
Q4 | $1.21M | Sell |
114,911
-68,229
| -37% | -$721K | ﹤0.01% | 2113 |
|
|
2022
Q3 | $824K | Buy |
183,140
+98,042
| +115% | +$441K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $340K | Buy |
85,098
+31,400
| +58% | +$125K | ﹤0.01% | 3827 |
|
|
2022
Q1 | $393K | Sell |
53,698
-138,517
| -72% | -$1.01M | ﹤0.01% | 4014 |
|
|
2021
Q4 | $1.08M | Buy |
192,215
+101,739
| +112% | +$572K | ﹤0.01% | 2770 |
|
|
2021
Q3 | $579K | Sell |
90,476
-223,098
| -71% | -$1.43M | ﹤0.01% | 3488 |
|
|
2021
Q2 | $2.64M | Buy |
313,574
+65,460
| +26% | +$552K | ﹤0.01% | 1798 |
|
|
2021
Q1 | $2.6M | Buy |
248,114
+50,987
| +26% | +$535K | ﹤0.01% | 1826 |
|
|
2020
Q4 | $3.34M | Buy |
197,127
+42,281
| +27% | +$716K | ﹤0.01% | 1303 |
|
|
2020
Q3 | $1.99M | Buy |
154,846
+36,748
| +31% | +$472K | ﹤0.01% | 1474 |
|
|
2020
Q2 | $1.67M | Sell |
118,098
-240,503
| -67% | -$3.39M | ﹤0.01% | 1603 |
|
|
2020
Q1 | $3.3M | Buy |
358,601
+158,249
| +79% | +$1.46M | ﹤0.01% | 936 |
|
|
2019
Q4 | $2.99M | Buy |
200,352
+158,266
| +376% | +$2.36M | ﹤0.01% | 1123 |
|
|
2019
Q3 | $287K | Buy |
42,086
+16,352
| +64% | +$112K | ﹤0.01% | 3460 |
|
|
2019
Q2 | $311K | Buy |
+25,734
| New | +$311K | ﹤0.01% | 3426 |
|